Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Comparison of impact estimates for the scale up of coverage of magnesium sulphate for management of pre-eclampsia to 90%

From: Linking household surveys and health facility assessments to estimate intervention coverage for the Lives Saved Tool (LiST)

 

Baseline coverage (%)

Impact estimates

Maternal lives saved

Stillbirths prevented

Current

Updated

Diff

Current

Updated

Current

Updated

Benin

3

28

25

117

98

497

445

Burkina Faso

2

8

6

273

263

435

425

DRC

2

10

7

2338

2236

2070

2015

Ghana

4

64

60

177

84

885

532

Kenya

3

43

40

804

571

87

70

Namibia

3

50

47

17

11

34

26

Rwanda

2

37

34

124

95

295

249

Senegal

2

26

24

186

158

281

254

Sierra Leone

4

47

43

313

211

278

215

Tanzania

2

29

27

717

594

641

570

Togo

3

33

30

88

71

380

330

Uganda

2

24

22

623

539

1638

1497

Zimbabwe

4

58

54

153

84

486

326

  1. Current = current default proxy value in LiST; Updated = updated estimates based on formulas; Diff = absolute difference between current default proxy and updated estimate
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us